300181.SZ Stock Analysis
30
Attractive
Based on Eyestock quantitative analysis, 300181.SZ`s fundamental data and valuation indicate an investment grade of Attractive at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research & development, production and distribution of pharmaceuticals as well as Chinese herbal medicines. The company is headquartered in Huzhou, Zhejiang and currently employs 2,132 full-time employees. The company went IPO on 2011-02-22. The Company’s main business is mainly involved in pharmaceutical manufacturing, among which the activities are involved in manufacture and sale of active pharmaceutical ingredients, tablets, capsules, granules, Lyophilized powders and other products. The main products include Wuling series, bailing tablets series and Chinese medicine drinking tablets series, among others. Through its subsidiaries, the Company is also engaged in pharmaceutical circulation.